Breyanzi (lisocabtagene maraleucel) - BMS
Kymriah (tisagenlecleucel-T) - Novartis
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
C. Voltin 1, 2; S. Escribano-Serrat 3, 4; B. Agridag Ucpinar 1; M. Gómez-Llobell 3; S. Einarsdottir 3; E. Luttwak 5; B. S. Imber 6; R. Shouval 3, 7; H. Schöder 1
 
Sep 29, 2026
 
Prev Next